(Q85109419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Erik Johnsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rolf Gjestad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Liv Mellesdal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Else-Marie Løberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rune A. Kroken

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20879830

22 July 2024

Hugo A. Jørgensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20879830

22 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20879830

22 July 2024

publication date

29 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 February 2020

http://www.tandfonline.com/doi/pdf/10.3109/08039488.2010.522729

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Nordic Journal of Psychiatry

22 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

192-202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

A Systematic Review of Mortality in Schizophrenia

14 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Schizophrenia and increased risks of cardiovascular disease

22 July 2024

2

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

22 July 2024

4

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Impact of substance use disorder on ADHD and its treatment.

22 July 2024

5

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

The case for practical clinical trials in psychiatry

22 July 2024

6

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

22 July 2024

7

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population.

22 July 2024

8

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

22 July 2024

9

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

The positive and negative syndrome scale (PANSS) for schizophrenia

22 July 2024

10

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

22 July 2024

11

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study

22 July 2024

13

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Selection Bias in Clinical Trials With Antipsychotics

22 July 2024

14

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Assessing substance use disorder in persons with severe mental illness

22 July 2024

15

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

A depression rating scale for schizophrenics

22 July 2024

16

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

22 July 2024

20

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

22 July 2024

21

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

22 July 2024

22

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

22 July 2024

23

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

22 July 2024

24

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

High remaining risk in poorly treated hypertension: the ‘rule of halves’ still exists

22 July 2024

25

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

22 July 2024

26

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Influence of body and arm position on blood pressure readings: an overview

22 July 2024

27

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Systematic difference between blood pressure readings caused by cuff type

22 July 2024

29

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Metabolic syndrome in people with schizophrenia: a review.

22 July 2024

30

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

The metabolic syndrome and schizophrenia

22 July 2024

31

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year

22 July 2024

32

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.

22 July 2024

33

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

22 July 2024

34

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review

22 July 2024

35

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program.

22 July 2024

36

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Can cardiovascular risk factors and lifestyle explain the educational inequalities in mortality from ischaemic heart disease and from other heart diseases? 26 year follow up of 50,000 Norwegian men and women

22 July 2024

37

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

22 July 2024

38

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Disparities in diabetes care: impact of mental illness.

22 July 2024

39

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

22 July 2024

40

1 reference

https://api.crossref.org/works/10.3109/08039488.2010.522729

22 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20879830%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference